Ophthalmic Pharmacology & Drug Delivery
This track focuses on pharmaceutical advances and innovative drug delivery systems in ophthalmology. Sessions will cover the pharmacokinetics and pharmacodynamics of ocular drugs, including anti-VEGF agents, corticosteroids, and immunomodulators. Emphasis will be placed on the development of sustained-release implants, nanoparticles, and gene-based drug carriers. Experts will explore the clinical applications of novel eye drops, intravitreal injections, and systemic therapies for diseases such as uveitis, AMD, and glaucoma. Attendees will learn about regulatory considerations, drug toxicity monitoring, and strategies for improving patient adherence. Real-world data on efficacy and safety profiles will be shared alongside clinical trial updates. This track is essential for clinicians, researchers, and pharmaceutical professionals dedicated to advancing drug therapy and optimizing treatment delivery in ocular care.